Niagen Bioscience, Inc. (NAGE)
4.89
+0.16
(+3.38%)
USD |
NASDAQ |
Apr 24, 11:40
Niagen Bioscience Total Liabilities (Quarterly) : 29.87M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 21.15M |
| Nephros, Inc. | 3.439M |
| Clover Health Investments Corp. | 232.31M |
| Corcept Therapeutics, Inc. | 190.22M |
| Protalix Biotherapeutics, Inc. | 34.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.41M |
| Shareholders Equity (Quarterly) | 76.53M |
| Debt to Equity Ratio | 0.0368 |
| Current Ratio | 4.86 |
| Net Debt Paydown Yield | 0.00% |